The effect of IV ketamine in patients with major depressive disorder and elevated features of borderline personality disorder
Authors:
- 26 July 2022
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 315, 13-16
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Mental Health (R01 MH107183)
- National Institutes of Health
This publication has 20 references indexed in Scilit:
- Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxietyJournal of Psychiatric Research, 2014
- EFFECTS OF KETAMINE ON EXPLICIT AND IMPLICIT SUICIDAL COGNITION: A RANDOMIZED CONTROLLED TRIAL IN TREATMENT-RESISTANT DEPRESSIONDepression and Anxiety, 2014
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled TrialAmerican Journal of Psychiatry, 2013
- Ketamine for Treatment-Resistant Unipolar DepressionCNS Drugs, 2012
- Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive DisorderThe Journal of Clinical Psychiatry, 2010
- A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major DepressionArchives of General Psychiatry, 2006
- Suicide in borderline personality disorder: A meta-analysisNordic Journal of Psychiatry, 2005
- Axis I Comorbidity of Borderline Personality DisorderAmerican Journal of Psychiatry, 1998
- Measurement of dissociative states with the Clinician‐Administered Dissociative States Scale (CADSS)Journal of Traumatic Stress, 1998
- Comparison of Beck Depression Inventories-IA and-II in Psychiatric OutpatientsJournal of Personality Assessment, 1996